These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 23928147)

  • 1. Preparation, characterization, biodistribution and antitumor efficacy of hydroxycamptothecin nanosuspensions.
    Han M; Liu X; Guo Y; Wang Y; Wang X
    Int J Pharm; 2013 Oct; 455(1-2):85-92. PubMed ID: 23928147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 10-Hydroxycamptothecin (HCPT) nanosuspensions stabilized by mPEG
    Yang L; Hong J; Di J; Guo Y; Han M; Liu M; Wang X
    Int J Nanomedicine; 2017; 12():3681-3695. PubMed ID: 28553107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a chemically stable 10-hydroxycamptothecin nanosuspensions.
    Pu X; Sun J; Wang Y; Wang Y; Liu X; Zhang P; Tang X; Pan W; Han J; He Z
    Int J Pharm; 2009 Sep; 379(1):167-73. PubMed ID: 19505545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
    Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y
    J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles.
    Yang L; Cui F; Cun D; Tao A; Shi K; Lin W
    Int J Pharm; 2007 Aug; 340(1-2):163-72. PubMed ID: 17482779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmaceutical evaluation of hydroxycamptothecin nanosuspensions with the action of inhibiting P-gp].
    Pu XH; Sun J; Qin YM; Zhang X; Zhang P; He ZG
    Yao Xue Xue Bao; 2011 Jul; 46(7):834-8. PubMed ID: 22010354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nanoparticulate drug-delivery system for glaucocalyxin A: formulation, characterization, increased in vitro, and vivo antitumor activity.
    Han M; Li Z; Guo Y; Zhang J; Wang X
    Drug Deliv; 2016 Sep; 23(7):2457-2463. PubMed ID: 25715810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A stabilizer-free and organic solvent-free method to prepare 10-hydroxycamptothecin nanocrystals: in vitro and in vivo evaluation.
    Yang X; Liu Y; Zhao Y; Han M; Guo Y; Kuang H; Wang X
    Int J Nanomedicine; 2016; 11():2979-94. PubMed ID: 27382284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and cytotoxic activity of hydroxycamptothecin nanosuspensions.
    Zhao YX; Hua HY; Chang M; Liu WJ; Zhao Y; Liu HM
    Int J Pharm; 2010 Jun; 392(1-2):64-71. PubMed ID: 20302926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Drug Payload 10-Hydroxycamptothecin Nanosuspensions Stabilized by Cholesterol-PEG: In Vitro and In Vivo Investigation.
    Yang L; Jiang J; Hong J; Di J; Liao Y; Kuang H; Wang X
    J Biomed Nanotechnol; 2015 Apr; 11(4):711-21. PubMed ID: 26310077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 10-Hydroxycamptothecin loaded nanoparticles: preparation and antitumor activity in mice.
    Zhang L; Yang M; Wang Q; Li Y; Guo R; Jiang X; Yang C; Liu B
    J Control Release; 2007 Jun; 119(2):153-62. PubMed ID: 17400320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxycamptothecin-loaded nanoparticles enhance target drug delivery and anticancer effect.
    Wang A; Li S
    BMC Biotechnol; 2008 May; 8():46. PubMed ID: 18454874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced tumor targeting and antitumor efficacy via hydroxycamptothecin-encapsulated folate-modified N-succinyl-N'-octyl chitosan micelles.
    Zhu H; Cao J; Cui S; Qian Z; Gu Y
    J Pharm Sci; 2013 Apr; 102(4):1318-32. PubMed ID: 23400693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid nanoparticles loaded with 10-hydroxycamptothecin-phospholipid complex developed for the treatment of hepatoma in clinical application.
    Wei W; Shi SJ; Liu J; Sun X; Ren K; Zhao D; Zhang XN; Zhang ZR; Gong T
    J Drug Target; 2010 Aug; 18(7):557-66. PubMed ID: 20131981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying.
    Zhang X; Pan W; Gan L; Zhu C; Gan Y; Nie S
    Chem Pharm Bull (Tokyo); 2008 Dec; 56(12):1645-50. PubMed ID: 19043233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxycamptothecin nanoparticles based on poly/oligo (ethylene glycol): Architecture effects of nanocarriers on antitumor efficacy.
    Guo Y; Wang T; Qiu H; Han M; Dong Z; Wang X; Wang Y
    Eur J Pharm Biopharm; 2019 Jan; 134():178-184. PubMed ID: 30529294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and
    Zhou T; Tang X; Zhang W; Feng J; Wu W
    Drug Deliv; 2019 Dec; 26(1):673-679. PubMed ID: 31266376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular target delivery of 10-hydroxycamptothecin with solid lipid nanoparticles against multidrug resistance.
    Liu M; Chen D; Wang C; Chen X; Wen Z; Cao Y; He H
    J Drug Target; 2015; 23(9):800-5. PubMed ID: 25766079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Honokiol nanosuspensions: preparation, increased oral bioavailability and dramatically enhanced biodistribution in the cardio-cerebro-vascular system.
    Han M; Yu X; Guo Y; Wang Y; Kuang H; Wang X
    Colloids Surf B Biointerfaces; 2014 Apr; 116():114-20. PubMed ID: 24448177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, characterization and targeting of micronized 10-hydroxycamptothecin-loaded folate-conjugated human serum albumin nanoparticles to cancer cells.
    Li Q; Liu C; Zhao X; Zu Y; Wang Y; Zhang B; Zhao D; Zhao Q; Su L; Gao Y; Sun B
    Int J Nanomedicine; 2011; 6():397-405. PubMed ID: 21499429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.